logo

For the Inventor, By the Inventor

Lausanne, Switzerland

Université De Lausanne

Calculating rank
USPTO Granted Patents = 26

% Expired Patents = 30.8



Forward Citations = 219

Loading Chart...
Loading Chart...

55 inventors (with patents filed for the assignee):

goldMedal Olivier Michielin (5 out of 7 patents)

silverMedal Vincent Zoete (5 out of 10 patents)

bronzeMedal Thierry Pedrazzini (3 out of 4 patents)

4.  Jean Kadouche (3 out of 8 patents)

5.  Jean-Pierre Mach (3 out of 6 patents)

6.  Justyna Iwaszkiewicz (3 out of 4 patents)

7.  Martine Cerutti (3 out of 12 patents)

8.  Sylvie Choblet (3 out of 4 patents)

9.  Josee Golay (3 out of 4 patents)

10.  Pascal Schneider (3 out of 18 patents)

11.  Jean-Philippe Thiran (3 out of 6 patents)

12.  George Coukos (3 out of 5 patents)

13.  Christophe Bonny (2 out of 24 patents)

14.  Nathalie Dunkel (2 out of 2 patents)

15.  Stéphane Demotz (2 out of 2 patents)


Core Competencies:
Long Noncoding RNAs
Cardiac Fibrosis
Multispecific Antibodies
Cancer Immunotherapy
Fungicides
Kinase Mutants
Magnetic Resonance Imaging
Neurosurgical Stereotaxy
Synthetic Peptides
Intracellular Delivery
Biological Effectors
Polypeptide Regulation

26 patents:

1. 12649948 - Diagnostic, Prognostic And Therapeutic Uses Of Long Noncoding RNAs For Heart Disease And Regenerative Medicine (2026-06-09),
2. 12491205 - Methods And Compositions For Controlling Cardiac Fibrosis And Remodeling (2025-12-09),
3. 12478626 - KINASE MUTANTS AND USES THEREOF (2025-11-25),
4. 12378325 - Multispecific antigens binding fragments and multspecific antibodies (2025-08-05),
5. 12297276 - Anti-TEM1 antibodies and antigen-binding portions thereof (2025-05-13),
6. 12167731 - Fungicides to prevent and control fungal pathogens (2024-12-17),
7. 12104078 - Insect corneal type nanocoatings (2024-10-01),
8. 11738049 - Kinase mutants and uses thereof (2023-08-29),
9. 11193171 - Diagnostic, prognostic and therapeutic uses of long noncoding RNAS for heart disease and regenerative medicine (2021-12-07),
10. 10858626 - Adoptive immunotherapy for treating cancer (2020-12-08),
11. 10815310 - Multispecific antigen binding fragments and multispecific antibodies derived therefrom comprising mutant CH1 and CL-kappa domains (2020-10-27),
12. 10526412 - Anti APRIL (a proliferation-inducing ligand) antibodies and their uses for the prognosis and/or diagnosis of cancer (2020-01-07),
13. 10506368 - Method and a system for matching subscriptions with publications (2019-12-10),
14. 9631031 - Multispecific antigens binding fragments and multispecific antibodies derived therefrom comprising mutant CH1 and CL-κ domains (2017-04-25),
15. 8975370 - Inhibitor proteins of a protease and use thereof (2015-03-10),
Company Overview
Université De Lausanne is a prominent institution of higher education located in Lausanne, Switzerland. It specializes in a wide range of disciplines, including humanities, social sciences, life sciences, and medicine. The university is known for its commitment to research and innovation, fostering interdisciplinary collaboration across various fields. With a strong emphasis on academic excellence, it contributes significantly to advancements in knowledge and technology, making it a key player in the Swiss educational landscape.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

26 Patents

#13 in Lausanne

#503 in Switzerland

#24,826 in the World

Lausanne, CH
Lausanne, Switzerland

Université De Lausanne

Forward Citations = 219

55 inventors:

goldMedal Olivier Michielin (5 out of 7 patents)

silverMedal Vincent Zoete (5 out of 10 patents)

bronzeMedal Thierry Pedrazzini (3 out of 4 patents)

4.  Jean Kadouche (3 out of 8 patents)

5.  Jean-Pierre Mach (3 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Université De Lausanne. Retrieved from https://idiyas.com/company/universite-de-lausanne

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…